Veradigm | MDRX - Assets


Veradigm reported $1.5B in Assets for its fiscal quarter ending in December of 2022.





Assets Change Date
Alcidion AUD 118.08M 2.46M Dec/2025
Ambu A/S DKK 7.58B 94M Dec/2025
Amplifon EUR 3.53B 336.5M Sep/2025
Cardinal Health USD 58.08B 2.86B Dec/2025
Centene USD 76.75B 5.34B Dec/2025
Charles River Laboratories USD 7.14B 378.39M Dec/2025
Cigna USD 157.92B 0 Dec/2025
Coloplast 48.8B 429M Dec/2025
Computer Programs Systems USD 402.53M 3.12M Dec/2025
Convatec Group USD 3.52B 109.3M Dec/2024
CVS Health USD 253.54B 1.79B Dec/2025
Diasorin EUR 2.87B 257.21M Jun/2025
Elevance Health USD 121.49B 1.26B Dec/2025
General Electric Aerospace USD 130.17B 1.93B Dec/2025
Gulf Medical Proj AED 1.55B 85.18M Dec/2025
Humana USD 48.91B 810M Dec/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Laboratory Of America USD 18.39B 131.1M Dec/2025
Maximus USD 4.21B 138.66M Dec/2025
McKesson USD 84.19B 30M Dec/2025
Med Life RON 3.26B 116.56M Dec/2025
Molina Healthcare USD 15.56B 134M Dec/2025
Omnicell USD 1.97B 26.12M Dec/2025
Oriola-kd EUR 946.1M 22.7M Dec/2025
Owens Minor USD 2.45B 1.58B Dec/2025
Quest Diagnostics USD 16.23B 28M Dec/2025
Rede D'or Sao Luiz BRL 106.55B 3.48B Dec/2025
Siemens Healthineers EUR 44.27B 104M Dec/2025
Sonova Holding CHF 5.92B 468.2M Jun/2025
Supermax Corporation Bhd MYR 4.17B 125.99M Dec/2025
UnitedHealth USD 309.58B 5.69B Dec/2025
Veeva Systems USD 8.98B 882.19M Dec/2025
Veradigm USD 1.5B 185.94M Dec/2022
Xerox USD 10.07B 1.19B Sep/2025